Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Transcat, Inc. (TRNS)

101.51 +1.13 (+1.13%)
At close: November 6 at 4:00:00 PM EST
109.00 +7.49 (+7.38%)
After hours: November 6 at 7:56:35 PM EST
Trade TRNS on Coinbase
Chart Range Bar
Loading chart for TRNS
  • Previous Close 100.38
  • Open 102.27
  • Bid 93.11 x 200
  • Ask 94.32 x 100
  • Day's Range 100.59 - 103.26
  • 52 Week Range 50.23 - 110.47
  • Volume 172,516
  • Avg. Volume 140,625
  • Market Cap (intraday) 954.686M
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) 211.48
  • EPS (TTM) 0.48
  • Earnings Date (est.) Feb 2, 2027
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 110.80
  • Zacks Rating Bullish

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. It also provides calibration, repair, preventive maintenance, electrical safety inspection, and documentation and regulatory compliance services to hospital networks and healthcare facilities in the southeastern United States. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

www.transcat.com

1,413

Full Time Employees

March 28

Fiscal Year Ends

Industrials

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TRNS
78.94%
S&P 500 (^GSPC)
7.76%

1-Year Return

TRNS
74.96%
S&P 500 (^GSPC)
9.77%

3-Year Return

TRNS
17.16%
S&P 500 (^GSPC)
68.96%

5-Year Return

TRNS
12.64%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 97.09M
Earnings 2.41M
Profit Margin 2.49%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
20M
40M
60M
80M
-1.0%
0.0%
1.0%
2.0%

Analyst Insights

View More

Analyst Price Targets

100.00
110.80 Average
101.51 Current
119.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/21/2026
Analyst Northland Capital Markets
Rating Action Upgrade
Rating Outperform
Price Action Maintains
Price Target 95 -> 95

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.26%

  • Return on Assets (ttm)

    2.28%

  • Return on Equity (ttm)

    1.52%

  • Revenue (ttm)

    363.22M

  • Net Income Avi to Common (ttm)

    4.59M

  • Diluted EPS (ttm)

    0.48

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.76M

  • Total Debt/Equity (mrq)

    48.82%

  • Levered Free Cash Flow (ttm)

    19.42M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: